Monday, June 23, 2025 6/23/2025

Metasurface enhanced and machine learning aided spectrochemical liquid biopsy

Award Number: R21EB034411
ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/01/2023
PERIOD OF PERFORMANCE END DATE: 02/28/2026

Group Awards By:

View Award Description

Metasurface enhanced and machine learning aided spectrochemical liquid biopsy - PROJECT SUMMARY Liquid biopsy modalities that can non-invasively detect disease-associated biomarkers from biofluids can enable early cancer detection and patient monitoring with implications for improved survival rates. However, current methods have not achieved critical sensitivity and accuracy to be approved for population screening programs. New spectrochemical liquid biopsy methods, such as Raman and infrared spectroscopy, coupled with machine learning models are emerging as next-generation diagnostic modalities. Yet, fundamental physical limitations of light-matter interactions using conventional optical setups hinder the analytical performance of molecular spectroscopy techniques. Here, we propose to employ novel electromagnetic metasurfaces that can advance the analytical sensitivity and chemical selectivity of infrared absorption spectroscopy enabling its real-world applications in the biomedical field. Moreover, our innovative laser-based spectral imaging approach can achieve on-chip spectrometer-less chemical fingerprint retrieval eliminating clinically incompatible, complex, and bulky instrumentation requirements. The long-term goal of this project is to develop a rapid, label-free, portable, and non-invasive cancer detection platform based on sensitive and accurate chemometric liquid biopsy and machine learning-aided discrimination modalities. The overall objectives in this application are to (i) determine a potent metasurface design that can robustly extract chemical fingerprint information from a complex biosample matrix, (ii) identify optimized design parameters for spectral imaging-based on-chip fingerprint retrieval (iii) establish measurement protocols and data processing pipeline (iv) identify a machine learning model by which sensitive and accurate sample discrimination can be achieved. In the short term, we will pursue two specific aims: 1) develop novel engineered metasurfaces for sensitive and specific spectrochemical biofluid analysis and demonstrate spectrometer-less on-chip chemical fingerprinting 2) Test and validate the platform using biofluids from an ovarian cancer patient cohort and non-cancer controls. Our proposed approach is innovative because it catalyzes the state-of-the-art laser-based infrared spectral imaging technology with powerful nanophotonic tools to enable its impact in biomedical diagnostics and address an unmet medical need. In addition, the proposed interdisciplinary project is significant because it is expected to develop a non-invasive and accessible health screening platform that can ultimately impact the clinical management of cancer and the survival outcomes equitably among diverse populations.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $148,840 )
2025	2025	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	3	5/19/2025	NON-COMPETING CONTINUATION	$14,884
2025	2025	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	3	1/27/2025	NON-COMPETING CONTINUATION	$133,956
														Subtotal = $148,840

Issue Date FY: 2024 ( Subtotal = $223,260 )
2024	2024	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	2	5/27/2024	NON-COMPETING CONTINUATION	$22,326
2024	2024	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	2	2/7/2024	NON-COMPETING CONTINUATION	$200,934
														Subtotal = $223,260

Issue Date FY: 2023 ( Subtotal = $223,260 )
2023	2023	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	1	2/24/2023	NEW	$223,260
														Subtotal = $223,260

Grand Total All Awards = $595,360

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Metasurface enhanced and machine learning aided spectrochemical liquid biopsy

Award Number: R21EB034411

ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/01/2023

PERIOD OF PERFORMANCE END DATE: 02/28/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer